用塔克罗利斯治疗耐固醇结节性表皮炎:一个病例报告
1Ophthalmology, Faculty of Medicine, Al Baha University, Al Aqiq, SAU.
Cureus
|November 29, 2023
概括
局部使用的塔克罗利斯有效治疗了耐固醇结节性表皮质炎. 这项案例研究强调了塔克罗利斯作为这种痛苦的眼睛炎症的独特和成功的治疗选择.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
背景情况:
- 结节性表皮质炎呈现为痛苦的,红眼睛胀.
- 这种情况会导致长时间的炎症,通常比扩散性表皮硬化炎更痛苦.
- 像类固醇和NSAIDs这样的标准治疗在某些情况下可能是无效的.
研究的目的:
- 评估局部塔克罗利斯在治疗耐固醇结节性表皮质炎患者的疗效.
- 探索一种新的治疗方法来治疗强的眼睛炎症.
主要方法:
- 一名46岁的男性有1个月的结节性表皮硬化病史,初步接受了局部布雷迪尼索隆酸盐和口服二芬治疗.
- 由于患者表现出很小的改善和症状复发,治疗被切换为复合局部塔克罗利斯0.1%滴.
- 塔克罗利莫斯每天四次给药,持续六周,然后在另外六周内逐渐减少.
主要成果:
- 患者在局部塔克罗利斯治疗后显著抑制了炎症,并完全消除了表皮硬化症症状.
- 脑膜外皮病变的大小显著下降,表明有效控制疾病.
- 与最初的类固醇和NSAID疗法相比,塔克罗利莫斯的疗效更高.
结论:
- 局部使用的塔克罗利是对抗常规类固醇治疗的结节性表皮硬化症的高效治疗方法.
- 这一案例凸显了塔克罗利斯作为一种独特而有前途的治疗选择,用于管理难以治疗的表皮硬化症.
- 鉴于其在这种类固醇耐药病例中的成功,对治疗表皮硬化症的局部塔克罗利木斯进行进一步的研究是有必要的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168


